Upstream Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	45.46	325.89	25.83
Short-Term Investments	348.12	144.56	83.98
Cash & Short-Term Investments	393.58	470.45	109.81
Cash Growth	258.42%	328.42%	-
Accounts Receivable	0.94	0.61	0.1
Other Current Assets	23.95	8.29	7.09
Total Current Assets	418.27	479.16	117
Net Property, Plant & Equipment	2.06	2.37	0.2
Total Assets	420.52	481.72	117.2
Accounts Payable	2.55	4.04	1.99
Accrued Expenses	7.67	5.99	4.48
Current Portion of Leases	0.71	0.7	0.05
Total Current Liabilities	10.93	10.74	6.52
Long-Term Leases	0.85	1.13	2.87
Total Long-Term Liabilities	0.85	1.13	2.87
Total Liabilities	11.78	11.87	9.39
Common Stock	0.05	0.05	0
Additional Paid-in Capital	666.45	660.6	4.82
Accumulated Other Comprehensive Income	0.26	-0.03	0.02
Retained Earnings	-258.02	-190.78	-127.97
Total Common Shareholders' Equity	408.74	469.85	-123.13
Minority Interest	-	-	230.94
Shareholders' Equity	408.74	469.85	107.81
Total Liabilities & Equity	420.52	481.72	117.2
Total Debt	1.56	1.83	2.92
Net Cash (Debt)	392.02	468.62	106.89
Net Cash Growth	-16.35%	338.41%	-
Net Cash Per Share	10.04	34.25	36.19
Book Value	408.74	469.85	-123.13
Book Value Per Share	10.47	34.34	-41.68
Tangible Book Value	408.74	469.85	-123.13
Tangible Book Value Per Share	10.47	34.34	-41.68

Updated Aug 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q